Asklepios Bio Pharmaceutical, Inc. announced it raised $200 Million in an initial filing from an offering of $200 Million
Asklepios Bio Pharmaceutical, Inc. announced it raised $200 Million in an initial filing from an offering of $200 Million
05/29/19, 5:39 PM
Location
Money raised
$200 million
Industry
biotechnology
Company Info
Location
20 tw alexander drive
durham, north carolina, united states
Additional Info
AskBio is a leading, clinical-stage gene therapy company dedicated to developing AAV gene therapies for genetic disorders. Learn more about our gene therapy technology and current clinical trials.